TB Intensive Workshop

Date: September 15-18, 2020
Location: 225 Warren Street, 1st Floor, West Wing, Newark, NJ 07103

COURSE DESCRIPTION & OVERALL GOAL
This workshop for clinicians provides comprehensive information on the application of principles for the diagnosis and treatment of TB, as well as the management of TB in special populations. Topics include transmission and pathogenesis, diagnosis and treatment, drug resistance, TB-HIV co-infection, TB in children and adolescents, and key aspects of patient management. The format includes lectures, interactive discussions, and case studies.

AGENDA

WHO SHOULD ATTEND
The workshop is designed for physicians, nurses and healthcare professionals who are involved in the diagnosis and management of TB patients. Individuals who work in the following settings would benefit from attending this workshop:

  • TB Programs
  • Health Departments
  • Hospital Infection Control
  • Correctional Facilities
  • Long Term Care Facilities
  • Immigrant & Refugee Health
  • Community Health Settings
  • College or University Health Services

WHY COURSE IS NEEDED
As the incidence of tuberculosis continues to decline, maintaining clinical and public health expertise in TB is particularly challenging. Therefore, ongoing training and education are important for healthcare providers to enhance skills in TB diagnosis, follow recommended treatment guidelines, and interact effectively with public health agencies. This type of training is also important for new clinicians working in TB control or other settings.

OBJECTIVES
Upon completion of this workshop, participants should be better able to:

  • List approaches for addressing clinical and social challenges in the management of patients with tuberculosis to achieve successful outcomes.
  • Interpret epidemiologic trends to better screen and treat groups who are at high risk for tuberculosis.
  • Implement recommendations for prompt diagnosis, appropriate treatment and effective management of tuberculosis disease.
  • Integrate current recommendations for the prevention and management of tuberculosis in children and adolescents.
  • Develop strategies for the care of TB patients with co-morbidities to ensure prompt diagnosis, integrated treatment, and effective management.
  • Apply the latest advances for assessing risk, testing and treating TB infection to prevent development of disease.

COURSE REQUIREMENTS
This course will build upon basic TB concepts. Prior to the course, it is recommended that participants review the CDC’s Core Curriculum on Tuberculosis: What the Clinician Should Know (Available at: http://www.cdc.gov/tb/education/corecurr/index.htm). In order to meet the learning objectives and receive continuing education credits, participants are required to attend the entire course, and complete an evaluation form. A post-course follow-up evaluation will be sent within 1 month of the course.

CONTINUING EDUCATION INFORMATION

http://jointaccreditation.org/sites/default/files/Jointly%20Accredited%20Provider%20TM.jpgIn support of improving patient care, Rutgers Biomedical and Health Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CME: Rutgers Biomedical and Health Sciences designates this live activity for a maximum of 24.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE: This activity is awarded 24.0 contact hours (60 minute CH). Nurses should only claim those contact hours actually spent participating in the activity.

DISCLOSURE POLICY
All individuals who affect content of continuing education activities are required to disclose to the audience any real or apparent conflict of interest related to the activity. The activity faculty are further required to disclose discussion of off-label/investigational uses in their presentations. These disclosures will be made to the audience at the time of the activity.

REGISTRATION INFORMATION & FEE
Registration Fee: $100

Please note that registration involves a two-step process.
Step 1: Please click on the link to complete the registration form.  
Step 2: After the registration form has been received, you will receive an email with a separate link to process your payment of the $100 registration fee.
Payment can be made via electronic check or credit/debit card. Purchase order payments are also acceptable.
A confirmation email will be sent after both steps of the registration process have been completed.

CANCELLATION INFORMATION
We reserve the right to modify the activity content, faculty and activities, and to cancel this activity, if necessary. If you are unable to attend, please inform us as soon as possible so that others may be accommodated.

FUNDING DISCLOSURE
Funding for this conference was made possible in part by the Centers for Disease Control and Prevention. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does the mention of trade names, commercial practices, or organizations imply endorsement by the U.S. government.

If you require an accommodation because of a disability, or if you have any additional needs or other questions, please contact Olivia Dupont at
od94@njms.rutgers.edu

  • FACULTY

    John Bernardo, MD
    Professor of Medicine
    Boston University School of Medicine

    Janet Cashman, RN-BC
    TB Clinic Nurse Manager
    Morris County Tuberculosis Clinic
    Morristown Medical Center

    Henry Fraimow, MD
    Assistant Professor of Medicine
    Cooper Medical School of Rowan University

    Barry Kreiswirth, PhD
    Director, TB Center
    Public Health Research Institute

    Alfred Lardizabal, MD
    Executive Director
    Global Tuberculosis Institute

    George McSherry, MD
    Chief, Pediatric Infectious Disease Division
    Penn State Children's Hospital

    Amee Patrawalla, MD, MPH 
    Medical Director 
    Global Tuberculosis Institute

    Chris Vinnard, MD, MPH, MSCE 
    Associate Professor
    Rutgers New Jersey Medical School

    Mark Wolman, MPH 
    Program Manager, TB Control 
    Global Tuberculosis Institute

    Patricia Woods, RN, MSN 
    Nurse Consultant, TB Program
    New Jersey Department of Health



     

    PLANNING COMMITTEE

    Anita Khilall, MPH - Activity Director
    Program Director, Education & Training
    Global Tuberculosis Institute

    Alfred Lardizabal, MD
    Executive Director
    Global Tuberculosis Institute


    Olivia Dupont, MPH
    Health Educator
    Global Tuberculosis Institute

    Mavis Faulknor, APN, FHNP-BC, RD, CDE
    Nurse Manager, Lattimore Practice
    Global Tuberculosis Institute